Pharmaceutical Supply – Prednisone Tablets

The contract entails the manufacture and supply of Prednisone Tablets identified by NSN 6505011460539 and NDC 00004-2832-81 under CAGE code 01769, ensuring full compliance with Department of Defense and Food and Drug Administration standards. The product is intended for military and federal healthcare use and must meet stringent quality, safety, and regulatory requirements established by both agencies to guarantee consistency and efficacy for end users. The contract is classified as a subcontract under NAICS code 325412, which corresponds to pharmaceutical preparation manufacturing, and is managed by the Defense Logistics Agency under the Department of Defense. The solicitation was posted on August 9, 2026, and is linked to the procurement instrument SPE2DX25D8022 with delivery order SPE2D926F8106, indicating an active and ongoing fulfillment process. While specific quantities and delivery timelines are not outlined in the provided data, the contract is positioned to support sustained operational readiness and pharmaceutical inventory needs across DoD facilities. Performance is expected to occur under the jurisdiction of the DLA, with adherence to federal procurement protocols and pharmaceutical manufacturing best practices required throughout the supply chain. The nature of the agreement underscores its critical role in maintaining a reliable, secure, and compliant supply of a widely used corticosteroid for military medical services.